In 2025, baby KJ Muldoon became the first person to receive a personalized gene editing treatment, which likely saved his life. But the scientific advances that made the groundbreaking treatment ...
The Phase 1/2 FUNCTION-DMD study will enroll ambulatory patients and is designed to evaluate safety, tolerability, and efficacy, including dystrophin protein expression and functional outcomes. "The ...
Apple’s iOS 27 could redefine smartphone photography and AI interaction with smarter editing tools, improved Siri, and deeper ...
Think you can’t get any real work done on your phone? Think again. The mobile versions of Word, Excel, OneNote, and other ...
One thing urologists and video editors have in common? Stress. While the two jobs couldn't be more different, they share the ...
Conference Call and Webcast Today at 8:30 a.m. ETPositive 12-month data from the OCU410 Phase 2 ArMaDa clinical trial for geographic atrophy (GA) ...
Readout to Include One-Year Cohort 1 Results and Early Cohort 2 Data; Webcast Conference Call Planned to Review RIDGE-1 Data ...
Transportation Authority of Marin officials plan to use the technology to speed up research, reports and other functions.
Individuals that share the same deletion of a portion of chromosome 16 are at risk of developing neurodevelopmental disorders ...
CMF today launched its third smartwatch—the CMF Watch Pro 3. The smartwatch is a major upgrade to the Watch Pro 2 that was launched in 2024, bringing a brighter screen, improved heart rate, sleep ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results